COVID-19: The therapeutic landscape

Catharine I. Paules; Anthony S. Fauci

doi:10.1016/j.medj.2021.04.015

COVID-19: The therapeutic landscape

Catharine I. Paules, Anthony S. Fauci

Research output: Contribution to journal › Article › peer-review

17 Scopus citations

Abstract

Therapeutics for hospitalized COVID-19 patients were identified through a robust research response with several lessons learned: clinical trial data should guide therapeutic use, results should not be extrapolated between disease stages, and robust studies should be designed to give clinically relevant data. These lessons should be applied to the outpatient research response.

Original language	English (US)
Pages (from-to)	493-497
Number of pages	5
Journal	Med
Volume	2
Issue number	5
DOIs	https://doi.org/10.1016/j.medj.2021.04.015
State	Published - May 14 2021

All Science Journal Classification (ASJC) codes

General Medicine

Access to Document

10.1016/j.medj.2021.04.015

Cite this

@article{0d4cfa30e7f94cf0893980e110f65a61,

title = "COVID-19: The therapeutic landscape",

abstract = "Therapeutics for hospitalized COVID-19 patients were identified through a robust research response with several lessons learned: clinical trial data should guide therapeutic use, results should not be extrapolated between disease stages, and robust studies should be designed to give clinically relevant data. These lessons should be applied to the outpatient research response.",

author = "Paules, {Catharine I.} and Fauci, {Anthony S.}",

note = "Publisher Copyright: {\textcopyright} 2021 Elsevier Inc.",

year = "2021",

month = may,

day = "14",

doi = "10.1016/j.medj.2021.04.015",

language = "English (US)",

volume = "2",

pages = "493--497",

journal = "Med",

issn = "2666-6359",

publisher = "Cell Press",

number = "5",

}

TY - JOUR

T1 - COVID-19

T2 - The therapeutic landscape

AU - Paules, Catharine I.

AU - Fauci, Anthony S.

PY - 2021/5/14

Y1 - 2021/5/14

N2 - Therapeutics for hospitalized COVID-19 patients were identified through a robust research response with several lessons learned: clinical trial data should guide therapeutic use, results should not be extrapolated between disease stages, and robust studies should be designed to give clinically relevant data. These lessons should be applied to the outpatient research response.

AB - Therapeutics for hospitalized COVID-19 patients were identified through a robust research response with several lessons learned: clinical trial data should guide therapeutic use, results should not be extrapolated between disease stages, and robust studies should be designed to give clinically relevant data. These lessons should be applied to the outpatient research response.

UR - http://www.scopus.com/inward/record.url?scp=85109427999&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85109427999&partnerID=8YFLogxK

U2 - 10.1016/j.medj.2021.04.015

DO - 10.1016/j.medj.2021.04.015

M3 - Article

C2 - 33899041

AN - SCOPUS:85109427999

SN - 2666-6359

VL - 2

SP - 493

EP - 497

JO - Med

JF - Med

IS - 5

ER -

COVID-19: The therapeutic landscape

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this